Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RA PHARMACEUTICALS, INC.”

115 pharma patents match "RA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 115
Index total 30,257
Page 2 / 5

Quick answer

This filtered view shows 115 pharmaceutical patents matching "RA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

115 results for “RA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 11819573

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

  2. US 11819572

    Treatment of pain by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

  3. US 11814445

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  4. US 11813357

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  5. US 11814444

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  6. US 11759459

    Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 19, 2023 · Expires Sep 14, 2043

    granted

  7. US 11752190

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted

  8. US 11723949

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted

  9. US 11707503

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  10. US 11535650

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted

  11. US 11530244

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

  12. US 11505575

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  13. US 11452691

    Compositions of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

  14. US 11426348

    Compositions of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Aug 30, 2022 · Expires Aug 25, 2042

    granted

  15. US 11357727

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  16. US 11311486

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted

  17. US 11304904

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  18. US 11278494

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  19. US 11185506

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  20. US 11179336

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  21. US 11123399

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted

  22. US 11040011

    Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

    Pacira Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted

  23. US 11033495

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  24. US 11014965

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted May 25, 2021 · Expires May 20, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.